Aberrant expression of caspase 14 in salivary gland carcinomas

Journal of Oral Pathology and Medicine

Volumn 44, Issue 6, 2015, Pages 444-448

  Lemound, Juliana ^a   Stucki Koch, Angelika ^a   Stoetzer, Marcus ^a   Kokemüller, Horst ^a   Gellrich, Nils Claudius ^a   Kreipe, Hans ^a   Hussein, Kais ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Caspase 14; Filaggrin; GATA3; Salivary gland carcinoma

Indexed keywords

CASPASE 14; FILAGGRIN; KI 67 ANTIGEN; TRANSCRIPTION FACTOR GATA 3; GATA3 PROTEIN, HUMAN; INTERMEDIATE FILAMENT PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER SURVIVAL; CHROMOSOME 19P; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECURRENCE FREE SURVIVAL; SALIVARY GLAND; SALIVARY GLAND CARCINOMA; TUMOR DIFFERENTIATION; TUMOR FREE SURVIVAL; BIOSYNTHESIS; ENZYMOLOGY; GENE AMPLIFICATION; GENETICS; HEAD AND NECK TUMOR; MIDDLE AGED; PATHOLOGY; PROCEDURES; SALIVARY GLAND TUMOR; SQUAMOUS CELL CARCINOMA; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; CARCINOMA, SQUAMOUS CELL; CASPASE 14; FEMALE; GATA3 TRANSCRIPTION FACTOR; GENE AMPLIFICATION; GENETIC LOCI; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; INTERMEDIATE FILAMENT PROTEINS; KI-67 ANTIGEN; MALE; MIDDLE AGED; SALIVARY GLAND NEOPLASMS;

EID: 84947765152     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/jop.12253     Document Type: Article

References (34)

1. Thornberry NA. Caspases: key mediators of apoptosis. Chem Biol 1998; 5: R97-103.
2. McIlwain DR, Berger T, Mak TW. Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol 2013; 5: a008656.
3. Van de Craen M, Van Loo G, Pype S, et al. Identification of a new caspase homologue: caspase-14. Cell Death Differ 1998; 5: 838-46.
4. Shi Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 2002; 9: 459-70.
5. Eckhart L, Declercq W, Ban J, et al. Terminal differentiation of human keratinocytes and stratum corneum formation is associated with caspase-14 activation. J Invest Dermatol 2000; 115: 1148-51.
6. Lippens S, Kockx M, Knaapen M, et al. Epidermal differentiation does not involve the pro-apoptotic executioner caspases, but is associated with caspase-14 induction and processing. Cell Death Differ 2000; 7: 1218-24.
7. Denecker G, Hoste E, Gilbert B, et al. Caspase-14 protects against epidermal UVB photodamage and water loss. Nat Cell Biol 2007; 9: 666-74.
8. Alibardi L, Dockal M, Reinisch C, Tschachler E, Eckhart L. Ultrastructural localization of caspase-14 in human epidermis. J Histochem Cytochem 2004; 52: 1561-74.
9. Kam DW, Charles AK, Dharmarajan AM. Caspase-14 expression in the human placenta. Reprod Biomed Online 2005; 11: 236-43.
10. Krajewska M, Kim H, Shin E, et al. Tumor-associated alterations in caspase-14 expression in epithelial malignancies. Clin Cancer Res 2005; 11: 5462-71.
11. White L, Dharmarajan A, Charles A. Caspase-14: a new player in cytotrophoblast differentiation. Reprod Biomed Online 2007; 14: 300-7.
12. Scharenberg C, Eckardt A, Tiede C, Kreipe H, Hussein K. Expression of caspase 14 and filaggrin in oral squamous carcinoma. Head Neck Pathol 2013; 7: 327-33.
13. Hsu S, Yamamoto T, Borke J, et al. Green tea polyphenol-induced epidermal keratinocyte differentiation is associated with coordinated expression of p57/KIP2 and caspase 14. J Pharmacol Exp Ther 2005; 312: 884-90.
14. Wu M, Kodani I, Dickinson D, et al. Exogenous expression of caspase-14 induces tumor suppression in human salivary cancer cells by inhibiting tumor vascularization. Anticancer Res 2009; 29: 3811-8.
15. Denecker G, Ovaere P, Vandenabeele P, Declercq W. Caspase-14 reveals its secrets. J Cell Biol 2008; 180: 451-8.
16. Bergeron L, Gondran C, Oberto G, et al. Skin presenting a higher level of caspase-14 is better protected from UVB irradiation according to in vitro and in vivo studies. J Cosmet Dermatol 2012; 11: 111-21.
17. Aho S, Harding CR, Lee JM, Meldrum H, Bosko CA. Regulatory role for the profilaggrin N-terminal domain in epidermal homeostasis. J Invest Dermatol 2012; 132: 2376-85.
18. Rundhaug JE, Hawkins KA, Pavone A, et al. SAGE profiling of UV-induced mouse skin squamous cell carcinomas, comparison with acute UV irradiation effects. Mol Carcinog 2005; 42: 40-52.
19. Mikolajczyk J, Scott FL, Krajewski S, Sutherlin DP, Salvesen GS. Activation and substrate specificity of caspase-14. Biochemistry 2004; 43: 10560-9.
20. Hvid M, Johansen C, Deleuran B, Kemp K, Deleuran M, Vestergaard C. Regulation of caspase 14 expression in keratinocytes by inflammatory cytokines - a possible link between reduced skin barrier function and inflammation? Exp Dermatol 2011; 20: 633-6.
21. Eckhart L, Ban J, Fischer H, Tschachler E. Caspase-14: analysis of gene structure and mRNA expression during keratinocyte differentiation. Biochem Biophys Res Commun 2000; 277: 655-9.
22. Pistritto G, Jost M, Srinivasula SM, et al. Expression and transcriptional regulation of caspase-14 in simple and complex epithelia. Cell Death Differ 2002; 9: 995-1006.
23. Kuechle MK, Predd HM, Fleckman P, Dale BA, Presland RB. Caspase-14, a keratinocyte specific caspase: mRNA splice variants and expression pattern in embryonic and adult mouse. Cell Death Differ 2001; 8: 868-70.
24. Celli A, Mackenzie DS, Crumrine DS, et al. Endoplasmic reticulum Ca2 + depletion activates XBP1 and controls terminal differentiation in keratinocytes and epidermis. Br J Dermatol 2011; 164: 16-25.
25. Asselin-Labat ML, Sutherland KD, Vaillant F, et al. Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14. Mol Cell Biol 2011; 31: 4609-22.
26. Ballaun C, Karner S, Mrass P, et al. Transcription of the caspase-14 gene in human epidermal keratinocytes requires AP-1 and NFkappaB. Biochem Biophys Res Commun 2008; 371: 261-6.
27. Hsu S, Qin H, Dickinson D, et al. Expression of caspase-14 reduces tumorigenicity of skin cancer cells. In Vivo 2007; 21: 279-83.
28. Koenig U, Sommergruber W, Lippens S. Aberrant expression of caspase-14 in epithelial tumors. Biochem Biophys Res Commun 2005; 335: 309-13.
29. Fang HY, Chen CY, Hung MF, et al. Caspase-14 is an anti-apoptotic protein targeting apoptosis-inducing factor in lung adenocarcinomas. Oncol Rep 2011; 26: 359-69.
30. Wu YH, Lo HF, Chen SH, Chen H. Caspase-14 suppresses GCM1 acetylation and inhibits placental cell differentiation. FASEB J 2013; 27: 2818-28.
31. Jonigk D, Merk M, Hussein K, et al. Obliterative airway remodeling: molecular evidence for shared pathways in transplanted and native lungs. Am J Pathol 2011; 178: 599-608.
32. Hussein K, Horny HP, Busche G, et al. Systemic mastocytosis (SM) with associated BCR-ABL-positive myelogenous leukaemia (SM-AHNMD): evidence that mast cells do not belong to the leukaemic clone. Leukemia 2011; 25: 1050-3.
33. Walsh DS, Borke JL, Singh BB, et al. Psoriasis is characterized by altered epidermal expression of caspase 14, a novel regulator of keratinocyte terminal differentiation and barrier formation. J Dermatol Sci 2005; 37: 61-3.
34. Schwartz LE, Begum S, Westra WH, Bishop JA. GATA3 immunohistochemical expression in salivary gland neoplasms. Head Neck Pathol 2013; 7: 311-5.